Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. - Wikidata - wikimedia - TriplyDB

Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.

Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.

http://www.wikidata.org/entity/Q43207600

about

Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis Impact of pre-operative positron emission tomography in gallbladder cancer 18F-FDG PET/CT Imaging of Gallbladder Adenocarcinoma - A Pictorial Review.Biliary tract cancers: SEOM clinical guidelines Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report.(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours.Evolving concepts in primary sclerosing cholangitis.Gallbladder cancer: can newer insights improve the outcome?Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.Imaging bile duct tumors: staging.The surgical management of gallbladder cancer.The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT.Muscle metastases from gallbladder cancer.Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis An Oncocytic Variant of Intraductal Papillary Neoplasm of the Bile Duct that Formed a Giant Hepatic Cyst.Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection.Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the 18F-FDG PET/CT Findings.Ability of FDG-PET/CT in the detection of gallbladder cancer.

P2860

Q33594891-7013452A-D9A1-4B87-9897-2AA5B9BD65FE Q33627586-4A025AA9-FE56-46C1-B692-00499B9EFD1E Q33639345-51AF4804-59C6-481A-8A61-4729389DAAD1 Q34074069-74DBBA4A-E9FB-4590-A59D-9E9FD64A950A Q34846267-88D65664-676A-48AC-8B46-08C083E69B4F Q35012158-95B1C1CC-3661-4781-AD26-C3A247B40512 Q35805873-AA07BB3E-4090-4E7E-B42E-7B4002470752 Q36047838-FB74C897-CE29-4A90-8F57-8C789C488A91 Q36400234-85E9571C-D963-42BE-8003-9A618C90F03E Q36689250-A787D956-2C56-4150-B805-D6158A433D80 Q37077299-B6099375-5849-4D46-A75B-656B6AAE610B Q37192828-50221453-4562-45C2-9D0C-441D8CEE9609 Q37957967-216190A3-A3AA-4DF9-B350-276DF144D7BA Q37968331-E45F29C0-920D-4DF3-AE62-CEF6065E5A8D Q38030862-6F14F6DD-0317-4C76-880E-2F019C924151 Q38059510-2622A90B-6E2F-4C8F-96FA-A911124DD884 Q38116396-8B6882F2-7B3B-49E4-BFA9-1C5D13E647AE Q38243069-A2BCB288-9EFE-46F9-87FA-11EB1011326D Q38400584-43DABDAA-66D7-4B8F-BB04-EC4A9025E9C4 Q38622107-D3184DFF-EDE1-4518-8D9B-405568813E62 Q39368078-B601C8CB-0BA8-475D-9DB1-883CFCA47057 Q39825527-B5CB8417-CA44-4869-81B3-BB99CD87ABCB Q40554841-C2A82D3F-43B2-4007-B4C2-E236CFDC4216 Q42939124-96CC2F29-3BA4-483C-A66A-25AC57777E49 Q46506999-CADA3EE0-6300-4390-9082-D55A491114D1 Q49678493-1E091F40-D3B9-44CC-8095-79B01EB429D0 Q49884432-6F3114B0-0038-4CFE-B771-13BBCDA28A44 Q53090381-4EA4898F-3655-4A2E-88D3-5A59730F3055

P2860

Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.

http://www.wikidata.org/entity/Q43207600

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@en

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@nl

type

label

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@en

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@nl

prefLabel

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@en

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@nl

P1433

Q43207600-4066A102-7C2D-45D9-9F5B-543E701ED59C

P1476

Q43207600-443E5651-F5C7-4786-AF42-3418D38A78F7

P2093

Q43207600-155FF11B-93FD-467D-87B4-62EE121FECBD

Q43207600-40A188A2-A6B1-46DE-968B-08F2EDFA0DB2

Q43207600-46427994-4CE5-433F-8EF2-BE98F3B9BA0A

Q43207600-57D6AB86-5B99-4478-AAD7-8759E51B8B2A

Q43207600-8A6FC5A8-9C45-4070-ACE6-C183D4A41B0F

Q43207600-BB85ECEB-4E5F-451A-AE5C-39F27B870A5E

Q43207600-D879DAE4-B70D-4581-8CE4-4DD46D7CC7E4

Q43207600-E13090AD-15BB-4542-B477-4629F5892068

P2860

Q43207600-2ADC67A0-441F-442E-8761-1ACFEECC2DB5

Q43207600-704B1183-BBD6-4A47-B475-03795640E0C4

P304

Q43207600-C4C6A522-2885-4D96-82F7-1E4600C2A46E

P31

Q43207600-5813143D-07C7-4165-ABE0-B2368665EC02

P356

Q43207600-81819E65-DC3B-4377-A60E-7EED87F1E5C8

P433

Q43207600-AACD2155-7BE2-4FF5-9987-DD199746254B

P478

Q43207600-510F869F-FCA4-4122-8A52-A3F618A37AA7

P577

Q43207600-62700AD3-674F-489D-B85B-0582867129CB

P698

Q43207600-97CB47E5-FDB9-4845-BDDF-89DC31EBA0D6

P921

Q43207600-FF32019C-F4AA-4749-BEFA-2675CB0F7F92

P356

S00535-009-0188-6

P1433

Journal of Gastroenterology

P1476

Clinical usefulness of 18F-FDG ...... cancer and cholangiocarcinoma.

@en

P2093

Byung Ik Kim

http://www.w3.org/2001/XMLSchema#string

Chong Il Sohn

http://www.w3.org/2001/XMLSchema#string

Dong Il Park

http://www.w3.org/2001/XMLSchema#string

Hong Joo Kim

http://www.w3.org/2001/XMLSchema#string

Jung Ho Park

http://www.w3.org/2001/XMLSchema#string

Seung Won Lee

http://www.w3.org/2001/XMLSchema#string

Woo Kyu Jeon

http://www.w3.org/2001/XMLSchema#string

Yong Kyun Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings.

Early bile duct cancer.

P304

560-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-009-0188-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20035356

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma